Top justice manners for Glaxo on overtime pay

<p>WASHINGTON (Reuters) – <span>The Supreme Court</span> ruled on Monday that <span>pharmaceutical companies</span> do not have to compensate overtime to their member who revisit doctors’ offices to foster their products, a brawl that had threatened a attention with billions of dollars in intensity liability.</p>
<p> By a 5-4 vote, a high justice handed a better to dual former <span>sales representatives</span> for a section of Britain’s <span>GlaxoSmithKline Plc</span>. They had appealed a statute by a U.S. <span>appeals court</span> in California that they were “outside sales” crew free from sovereign overtime compensate requirements.</p>
<p> That preference conflicted with an progressing statute by a 2nd U.S. Circuit Court of Appeals in New York that <span>pharmaceutical sales</span> member competent for overtime underneath a sovereign <span>Fair Labo...